Inactive Ingredient Search for Approved Drug Products

• Share
• Tweet
• Linkedin
• Pin it
• More sharing options
  • Linkedin
  • Pin it
• Email
• Print

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with G

	Quarter	Inactive Ingredient	Route of Administration	Dosage Form	Maximum Potency per unit dose	Maximum Daily Exposure	Status
3099	Q3 2021	GLYCERIN	TOPICAL	CLOTH	50.00 mg		Correction
3099	Q4 2021	GLYCERIN	TOPICAL	CLOTH	0.05 mg/mg		Correction
3082	Q3 2021	GLYCERIN	ORAL	SUSPENSION	23520.00 mg		MDE Replacement
3082	Q4 2021	GLYCERIN	ORAL	SUSPENSION		26208 mg	MDE Replacement
3128	Q3 2021	GLYCERYL DIBEHENATE	ORAL	POWDER, FOR SOLUTION	2.00 mg		MDE Replacement
3128	Q4 2021	GLYCERYL DIBEHENATE	ORAL	POWDER, FOR SOLUTION		2 mg	MDE Replacement
3158	Q3 2021	GLYCERYL MONO AND DIPALMITOSTEARATE	VAGINAL	CREAM	4.00 %w/w		MDE Replacement
3158	Q4 2021	GLYCERYL MONO AND DIPALMITOSTEARATE	VAGINAL	CREAM		160 mg	MDE Replacement
3162	Q3 2021	GLYCERYL MONOCAPRYLOCAPRATE	ORAL	CAPSULE	374.24 mg		MDE Replacement
3162	Q4 2021	GLYCERYL MONOCAPRYLOCAPRATE	ORAL	CAPSULE		501.9 mg	MDE Replacement
3256	Q3 2021	GUAR GUM	ORAL	TABLET, CHEWABLE, EXTENDED RELEASE	24.00 mg		MDE Replacement
3256	Q4 2021	GUAR GUM	ORAL	TABLET, CHEWABLE, EXTENDED RELEASE		36 mg	MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021